World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
39206
World Ranking
15373
National Ranking
814

Overview

Wolf O. Bechstein is affiliated with Goethe University Frankfurt in Germany and has a significant research presence in the field of Medicine, with a total of 357 publications. Their work prominently covers subfields including Surgery, Pulmonary and Respiratory Medicine, Oncology, Hepatology, and Epidemiology.

Their research topics are closely associated with liver and gastrointestinal cancers and diseases. Major themes include:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pancreatic and Hepatic Oncology Research
  • Gallbladder and Bile Duct Disorders
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Gastric Cancer Management and Outcomes

Bechstein has co-authored extensively with several researchers, including:

  • Andreas A. Schnitzbauer (60 publications)
  • Jan Heil (22 publications)
  • Stefan Zeuzem (21 publications)
  • Elsie Oppermann (21 publications)
  • Andreas Pascher (19 publications)

Their frequent publication venues demonstrate a broad interest in oncology and surgical research, with the following journals having the most publications:

  • Zeitschrift für Gastroenterologie (30 publications)
  • Journal of Clinical Oncology (11 publications)
  • Annals of Surgical Oncology (11 publications)
  • Cancers (6 publications)
  • HPB (5 publications)

Among recent papers, several notable studies include:

  • Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer (2021, JAMA Oncology)
  • Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial (2023, Journal of Clinical Oncology)
  • mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors (2020, Annals of Surgery)
  • Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial (2022, Journal of Clinical Oncology)
  • Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis (2021, British Journal of Surgery)

Best Publications

  • Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

    Helmut Oettle;Stefan Post;Peter Neuhaus;Klaus Gellert

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Bengt Glimelius;Graeme J Poston

  • Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

    Salah-Eddin Al-Batran;Nils Homann;Claudia Pauligk;Thorsten O Goetze

  • Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

  • Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

    Gunnar Folprecht;Thomas Gruenberger;Wolf O Bechstein;Hans-Rudolf Raab

  • Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

    Sven Jonas;Wolf O. Bechstein;Thomas Steinmüller;Martin Herrmann

  • Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

    Christoph Schuhmacher;Stephan Gretschel;Florian Lordick;Peter Reichardt

  • Extended resections for hilar cholangiocarcinoma.

    Peter Neuhaus;Sven Jonas;Wolf O. Bechstein;Rüdiger Lohmann

  • Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

    Salah-Eddin Al-Batran;Ralf D Hofheinz;Claudia Pauligk;Hans-Georg Kopp

  • Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

    Theo Ruers;Frits Van Coevorden;Cornelis J. A. Punt;Jean-Pierre E. N. Pierie

  • Neurotoxicity of calcineurin inhibitors: impact and clinical management.

    Wolf O. Bechstein

  • Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

    T J Vogl;S Kümmel;R Hammerstingl;M Schellenbeck

  • Randomized Trial of Surgery Versus Surgery Followed by Adjuvant Hepatic Arterial Infusion With 5-Fluorouracil and Folinic Acid for Liver Metastases of Colorectal Cancer

    Matthias Lorenz;Hans-Helge Müller;Harald Schramm;Heinz-Jochen Gassel

  • Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

    T. Ruers;C. Punt;F. Van Coevorden;J. P. E. N. Pierie

  • Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

    Edward K. Geissler;Andreas A. Schnitzbauer;Andreas A. Schnitzbauer;Carl Zülke;Philipp E. Lamby

  • The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence

    B Ringe;C Wittekind;W O Bechstein;H Bunzendahl

  • Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

    Emmanouil Fokas;Michael Allgäuer;Bülent Polat;Gunther Klautke

  • Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial

    Salah-Eddin Al-Batran;Nils Homann;Claudia Pauligk;Gerald Illerhaus

  • 6010 POSTER DISCUSSION Radiofrequency Ablation Combined With Systemic Treatment Versus Systemic Treatment Alone in Patients With Non- Resectable Colorectal Liver Metastases: a Randomized EORTC Intergroup Phase II Study (EORTC 40004)

    T. Ruers;C. Punt;F. van Coevorden;J. Ledermann

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983)

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

Frequent Co-Authors

Peter Neuhaus
Peter Neuhaus Charité - University Medicine Berlin
Stefan G. Tullius
Stefan G. Tullius Brigham and Women's Hospital
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Thomas J. Vogl
Thomas J. Vogl Goethe University Frankfurt
Rudolf Pichlmayr
Rudolf Pichlmayr Hanover University of Applied Sciences and Arts
Eva Herrmann
Eva Herrmann Goethe University Frankfurt
Peter M. Schlag
Peter M. Schlag Charité - University Medicine Berlin
Hans J. Schlitt
Hans J. Schlitt University of Regensburg
Werner Hohenberger
Werner Hohenberger University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Online education has opened up new avenues for pursuing healthcare careers with flexibility and affordability. Aspiring healthcare professionals can now access specialized programs from the comfort of home, helping them balance work, life, and study.

For those interested in administrative roles, securing the cheapest medical coding certification online can be a quick way to start working in medical billing and coding. This field is crucial in healthcare settings and offers entry-level job opportunities with solid earning potential.

If you’re passionate about patient care, there are numerous online nursing courses available, from associate to bachelor’s level. For advanced roles, nurses might consider online graduate degrees. Prospective nurse practitioners can search for the cheapest np school online to advance their clinical skills and tackle bigger responsibilities.

For those aiming at leadership, research, or academic positions, online nursing phd programs provide the highest level of nursing education and new career horizons. Whether you’re starting out or seeking to specialize further, online degrees in healthcare offer accessible pathways to a variety of rewarding professions.

Best Scientists Citing Wolf O. Bechstein

Trending Scientists

Recently Published Articles